Please check out my newsletter in which I cover this stock and its comparables : hxxps://aimtechstocks.substack.com/p/aim-tech-stocks-in-healthcare
thanks |
Ready to breakout in the top 25 gainers now |
integrate Zesty with Oracle Cerner and widely-used diagnostic booking systems (Cris and Soliton) will see 10 or more NHS trusts contracting in. ConfedExpo is
next week too. |
this week could be big NHS Hospital contract win week |
In the top 50 gainers on the leaderboard risers now |
can this be the week we see nhs england contract renewal and this rockets |
NHS ENGLAND Contract news should catapult this share due very soon |
strong buying from opening bell should rally today |
Getting press coverage now see below, i see a lot more people coming in today and tomorrow:
Induction Healthcare Group PLC - London-based software company serving healthcare providers and administrators - Expects to report revenue of GBP14.1 million in the year ended March 31, up from GBP13.6 million a year earlier. Adjusted earnings before interest, tax, depreciation and amortisation are expected to be in line with market expectation at about GBP300,000, swinging from a loss of GBP3.6 million. CEO Paul Tambeau says: "Our key focus this year was to stabilise the business, complete a cost containment programme, and put Induction onto a self-sustaining path without the need for immediate funding. I'm very pleased that we have delivered on these objectives." |
NHS England contract news should be coming in the next few days which will be a big number....multi-bagger in the making this little gem |
Still lossmaking though. EBITDA of 0.3mm = PBT of -1.7mm. |
 Induction Healthcare Group PLC
Full Year Trading Update
London, UK - 29 April 2024: Induction Healthcare Group PLC ("Induction", the "Company", or the "Group"; AIM: INHC), a leading digital health platform driving transformation of healthcare systems, today announces the following trading update for the year ending 31 March 2024.
Financial Highlights (unaudited)
· Revenues of approximately £14.1m (FY23: £13.6m), broken down as follows:
o Attend Anywhere: £8.5m
o Zesty: £4.9m
o Guidance: £0.7m
· Adjusted EBITDA* expected to be in line with market expectation at approximately £0.3m (FY23: -£3.6m)
· Gross margin improvement to 77.9% (FY23: 63.1%)
· Net cash £3.7m (31 March 2023: £4.3m)
* Adjusted EBITDA is Operating result from continuing operations before depreciation (£0.1m), amortisation (£4.3m) and net of non-cash/ non-operating items (£0.2m)
Operational Highlights
· New NHS patient portal contracts compensate for downward pressure on video pricing.
· Completed effective cost containment and margin enhancement programme.
· Achieved objective of self-sustaining growth and cash flow breakeven.
· Signed a total of £3.4m (includes previously-announced contracts) in contracts with NHS England Trusts to:
o Further integrate Zesty with Oracle Cerner and widely-used diagnostic booking systems (Cris and Soliton);
o Enhance Form Builder module to support waitlist validation; and
o Build new functionality, such as digitising maternity records.
All platform and product enhancements underpin valuable upsell opportunities for FY25.
· Launched Zesty in 4 new Trusts, including a new contract award in Q4 with George Elliot Hospital NHS Trust. Three additional Trusts are contracted to launch Zesty within the next 12 months.
· Successfully built and launched the first phase of our integrated product which enables a patient to view and launch their Attend Anywhere consultation from within Zesty. Five customers have already purchased the integrated functionality.
· NHS Wales agreed to a 9-month extension for £730,858 in order to prepare for a new procurement, which was expected under NHS procurement rules given the length of a new contract.
Induction expects to release its audited results for the year ending 31 March 2024 on 1 July 2024. |
In the top 50 gainers on the leaderboard risers and mms are ready to tick up |
can we see this break past 20.00+ today |
RNS OUT - Fabulous trading update and results this morning |
NHS ENGLAND CONTRACT SHOULD BE ANNOUNCED AND EXPECT ALOT MORE NHS CONTRACTS COMING AS THEY NOW HAVE THEIR NEW FINANCIAL BUDGETS.....GREAT TIME TO BUY |
Results and contract wins update coming next week may even bag next week |
NHS England Renewal and hospitals tend to buy in April make this very cheap and should double up in price between now and end of May |
results and new contracts should be due this week |
should post results next week |
news should be coming very soon |
Induction healthcare will be showcasing collaborative PEP solution with
@OracleHealth at 'Patient Portal UK (PPUK)', at the Oracle Health Collaboration Forum in London this week |
No desperation when you do your research .... NHS England is big customer look at the investor presentation yourself and 2 years ago and you'll see 2 year contracts signed now Zesty has been integrated and NHS app updates undertaken along the need for remote consultation being a big part of the NHS agenda across different areas...maternity being the new area of adoption ....expect some big number on the next Contract RNS news.....I've done my research ......on 11th April 2022 they got £6.6 million NHS England contract renewal....looking forward to the news in the coming days |
Desperation |
Remote consultation services in secondary care. Should see Induction Attend Anywhere ("AA") contracts have been successfully extended or renewed across NHS England ...expect 2-3 year contracts RNS very soon....this RNS should see share price bounce up past 20.00s |
Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
Hot Features
Premium
